Latest News

New research reveals big mutual funds prioritize political influence over shareholder value

FONTAINEBLEAU, France, SINGAPORE and SAN FRANCISCO, July 11, 2024 /PRNewswire/ -- As the US steels itself for the election in November, the possibility of a political shift in the White House seems high. Yet a new study suggests the outcome may also lead to very different voting behaviour among t...

2024-07-11 23:00 3427

DOM PÉRIGNON RÉVÉLATIONS 2024

BARCELONA, Spain, July 11, 2024 /PRNewswire/ -- On July 8th, the champagne Maison Dom Pérignon and itsChef de Cave Vincent Chaperon gathered artists and creators, chefs and sommeliers from the Dom Pérignon Society from all over the world inBarcelona for the 4th edition of its Révélations event, a...

2024-07-11 21:09 4263

Medit Appoints Han Ryu as CEO, Focusing on Customer-Centric Innovation

SEOUL, South Korea, July 11, 2024 /PRNewswire/ -- Medit, a global leader in dental 3D scanners and digital dentistry solutions, has appointedHan Ryu as its new CEO. Ryu brings with him over three decades of senior management experience in global medical device and healthcare companies, including ...

2024-07-11 21:00 4304

Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors

BEIJING, July 11, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided a business update from Dr. Gengchen Han, Chairman and CEO of Origin Agritech. Dear Shareholders, We are pleased to provide you with...

2024-07-11 21:00 6223

2024 Chengdu Tianfu Greenway International Cycling Race Concludes Successfully

CHENGDU, China, July 11, 2024 /PRNewswire/ -- On June 30, the 2024 China Chengdu Tianfu Greenway International Cycling Race concluded successfully at the Tianfu Olympic Sports Park inChengdu's Eastern New Area. Professional cyclists and cycling enthusiasts from around the world competed around Sa...

2024-07-11 20:42 3823

First Patient Dosed in Phase I Clinical Trial of YOLT-201

SHANGHAI, July 11, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced today the successful enrollment of the first patient in the Phase I clinical trial of YOLT-201, its independently developed in vivo g...

2024-07-11 20:11 2731

China Natural Resources Receives Nasdaq Notification Regarding Minimum Bid Requirements

HONG KONG, July 11, 2024 /PRNewswire/ -- On July 5, 2024, China Natural Resources, Inc. (NASDAQ: CHNR) (the "Company") received a letter from the Listing Qualifications Department of The Nasdaq Capital Market ("Nasdaq") notifying the Company that it is currently not in compliance with the minimum...

2024-07-11 20:10 5243

Mega Matrix Announced that "Queen of Revenge: Sister's Fury" has Started Filming on July 10, setting off a New Trend of Female-Oriented Short Drama.

PALO ALTO, Calif., July 11, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that the highly anticipated new high Female-Oriented Short Drama "Queen of Revenge: Sister's Fury" has Started Filming onJuly 10, 2024.

2024-07-11 20:00 4862

Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC

SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform. Sanyou Bio is a world-leading high-tech...

2024-07-11 20:00 3768

Moomoo Secures Seven New Patents; Bolstering Features with Latest Technological Advancements

JERSEY CITY, N.J., July 11, 2024 /PRNewswire/ --  The intuitive investment and trading platform moomoo proudly announces that its Research & Development affiliate has been granted seven additional patents in the first half of 2024. These new patents were awarded by the ...

2024-07-11 20:00 3384

ZTE continuously innovates optical network technologies, achieving fastest global market share growth

SHENZHEN, China, July 11, 2024 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology solutions, achieved the fastest growth in global optical network market share from 2Q23 to 1Q24, according to the reportOptical N...

2024-07-11 18:26 3714

"Bleach: Brave Souls" Now Available on the Nintendo Switch

TOKYO, July 11, 2024 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its hit 3D action gameBleach: Brave Souls is available on the Nintendo Switch from today,Thursday, July 11. See the original press release (https://www.klab.com/en/pres...

2024-07-11 18:10 3009

Guide Sensmart's Advanced Technology--Preferred Choice for Ensuring Sports Venue Security

NUREMBERG, Germany, July 11, 2024 /PRNewswire/ -- As the most anticipated Olympic sporting event approaches, ensuring venue security and equipment inspection has become increasingly critical in daily operations to accommodate global athletes and spectators. With decades of dedication to the therm...

2024-07-11 17:00 4379

/DISREGARD RELEASE: Solus Advanced Materials/

We are advised by Solus Advanced Materials that journalists and other readers should disregard the news release, Solus Advanced Materials significantly increases its supply of battery copper foil to North American customers, expanding influence in the global market, issued28-Jun-2024 over PR News...

2024-07-11 16:31 3320

Over 30 vessels to be constructed by Hengli this year

DALIAN, China, July 11, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn: Hengli Heavy Industries plans to commence construction on over 30 vessels this year, process nearly 500,000 tons of steel plates, and engage over 20,000 personnel at its yard in Changxing Island ofDalian, Liaoning...

2024-07-11 14:29 2521

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)

Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) TOKYO, July 11, 2024 /PRNewswire/ -- The National Cancer Center (Tokyo, Japan ) and TheUniversity of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a chimeric...

2024-07-11 14:21 3044

ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target as 'Prostate Cancer Patients Resistant to Hormone Therapy'

* IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. * Niclosamide-based metabolic anticancer drug aims to block signaling pathways that allow cancer cells to evade anticancer effects, potentially solving the issue ...

2024-07-11 14:07 3419

Official Swiss delegation experiences new frontiers in art tech at HKBU

HONG KONG, July 11, 2024 /PRNewswire/ -- A senior Swiss delegation led by Mr Guy Parmelin, Swiss Federal Councillor and Head of the Federal Department of Economic Affairs, Education and Research, visited Hong KongBaptist University (HKBU) on 5 July. The delegation was able to partake in the premi...

2024-07-11 13:34 2845

This is Nishan

QUFU, China, July 11, 2024 /PRNewswire/ -- According to Shandian News reports:  A mountain does not have to be high; its fame lies in the presence of immortals. Located approximately 30 kilometers southeast of Qufu's urban area, there stands a hill at an altitude of over 300 meters. Because of th...

2024-07-11 12:10 3068

MMTEC, Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HONG KONG, July 10, 2024 /PRNewswire/ -- MMTEC, Inc. (NASDAQ: MTC) ("MMTEC", "we", "our" or the "Company"), aChina-based technology company that provides access to the U.S. financial markets, today announced that onJuly 8, 2024, the Company received a notification letter (the "Notification Letter...

2024-07-11 05:00 5233